DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,755 filers reported holding DANAHER CORPORATION in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $580,306 | +2.3% | 2,339 | -1.1% | 0.04% | +7.5% |
| Q2 2023 | $567,360 | -4.8% | 2,364 | 0.0% | 0.04% | -9.1% |
| Q1 2023 | $595,823 | +94927.6% | 2,364 | 0.0% | 0.04% | -12.0% |
| Q4 2022 | $627 | -99.9% | 2,364 | 0.0% | 0.05% | -7.4% |
| Q3 2022 | $611,000 | +2.0% | 2,364 | 0.0% | 0.05% | +5.9% |
| Q2 2022 | $599,000 | -13.6% | 2,364 | 0.0% | 0.05% | -5.6% |
| Q1 2022 | $693,000 | -34.9% | 2,364 | -27.0% | 0.05% | -34.9% |
| Q4 2021 | $1,065,000 | -74.9% | 3,237 | -76.8% | 0.08% | -75.5% |
| Q3 2021 | $4,241,000 | +13.2% | 13,929 | -0.2% | 0.34% | +14.9% |
| Q2 2021 | $3,745,000 | +17.5% | 13,954 | -1.4% | 0.30% | +11.3% |
| Q1 2021 | $3,187,000 | +4586.8% | 14,159 | +4542.3% | 0.26% | +4316.7% |
| Q4 2020 | $68,000 | +1260.0% | 305 | +1120.0% | 0.01% | +500.0% |
| Q3 2020 | $5,000 | -16.7% | 25 | -30.6% | 0.00% | 0.0% |
| Q2 2020 | $6,000 | +100.0% | 36 | +44.0% | 0.00% | – |
| Q1 2020 | $3,000 | -25.0% | 25 | 0.0% | 0.00% | – |
| Q4 2019 | $4,000 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |